Characteristic, n (% column) | No drug dependence (N = 504,360, 98.5 %) | Drug dependence (N = 7,461, 1.5 %) |
---|---|---|
Age group, years | ||
< 45 | 56,969 (11.3) | 2,427 (32.5) |
45–64 | 118,758 (37.4) | 4,655 (62.4) |
65–74 | 121,737 (24.1) | 289 (3.9) |
> 74 | 136,896 (27.1) | 90 (1.2) |
Male gender | 283,718 (56.2) | 5,286 (70.9) |
Race | ||
White | 331,019 (65.6) | 2,703 (36.2) |
Black | 145,126 (28.8) | 4,594 (61.6) |
Asian | 21,946 (4.3) | 44 (0.6) |
Other | 6,269 (1.2) | 120 (1.6) |
Hispanic ethnicity | 71,346 (14.1) | 769 (10.3) |
Primary cause ESRD | ||
Diabetes | 232,612 (46.1) | 1,893 (25.4) |
Hypertension | 145,548 (28.9) | 2,568 (34.4) |
Glomerulonephropathy | 29,422 (5.8) | 637 (8.5) |
Other/Unknown | 96,778 (19.2) | 2,363 (31.7) |
Vascular access at initiation | ||
AVF | 70,741 (14.1) | 605 (8.2) |
AVG | 17,344 (3.5) | 227 (3.1) |
Catheter with maturing AVF | 78,717 (15.8) | 1,048 (14.1) |
Catheter with maturing AVG | 12,296 (2.5) | 226 (3.0) |
Catheter only | 320,720 (64.2) | 5,304 (71.6) |
No pre-dialysis nephrology care | 161,201 (32.0) | 4,073 (54.6) |
Medicaid insurance | 128,990 (25.6) | 3,731 (50.0) |